doi: 10.1084/jem.149.1.290.
Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses
- PMID: 153933
- PMCID: PMC2184736
- DOI: 10.1084/jem.149.1.290
Item in Clipboard
Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses
J Exp Med.
.
Abstract
Spleen cells from cyclophosphamide-treated mice responded in vitro to allogeneic stimulator cells but not to TNP-coupled syngeneic spleen cells. Similarly, cells from female mice, primed in vivo with syngeneic male cells, could not respond in vitro to male spleen cell stimulation if the mice were pretreated with cyclophosphamide. These results suggest that the precursor cells for H-2-restricted cytotoxic responses belong to a different T-cell subpopulation than the precursor cells for allogeneic responses.
Similar articles
-
Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures.Cancer Res. 1981 Mar;41(3):850-3. Cancer Res. 1981. PMID: 6450638
-
Recovery of the capacity for cytotoxic T cell generation in cyclophosphamide-treated mice by the addition of LYT-1/2- helper cells.Int J Immunopharmacol. 1980;2(4):341-4. doi: 10.1016/0192-0561(80)90034-x. Int J Immunopharmacol. 1980. PMID: 6970728
-
T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. III. Dissociation of primed cytolytic T-cell and efferent suppressor-T-cell activity following intravenous injection of trinitrophenol-modified syngeneic spleen cells.Cell Immunol. 1984 Jul;86(2):308-16. doi: 10.1016/0008-8749(84)90385-x. Cell Immunol. 1984. PMID: 6234068
-
Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction.J Exp Med. 1980 May 1;151(5):1196-212. doi: 10.1084/jem.151.5.1196. J Exp Med. 1980. PMID: 6445399 Free PMC article.
-
Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.J Immunol. 1988 Feb 1;140(3):723-9. J Immunol. 1988. PMID: 2448374
Cited by
-
Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells.J Clin Invest. 1987 Apr;79(4):1082-90. doi: 10.1172/JCI112922. J Clin Invest. 1987. PMID: 3494044 Free PMC article.
-
Immunotoxicity of immunotherapeutic agents.Springer Semin Immunopathol. 1985;8(4):347-59. doi: 10.1007/BF01857389. Springer Semin Immunopathol. 1985. PMID: 2418519 No abstract available.
-
Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.Cancer Immunol Immunother. 1989;29(4):255-60. doi: 10.1007/BF00199213. Cancer Immunol Immunother. 1989. PMID: 2502309 Free PMC article.
-
Rescue of anti-influenza A virus cytotoxic T-lymphocyte responses in chemotherapy-suppressed mice.J Virol. 1984 Jul;51(1):20-5. doi: 10.1128/JVI.51.1.20-25.1984. J Virol. 1984. PMID: 6610060 Free PMC article.
-
The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.Immunology. 1983 Mar;48(3):433-8. Immunology. 1983. PMID: 6219062 Free PMC article.
